Phio Pharmaceuticals Corp. (PHIO)

Phio Pharmaceuticals Statistics

Total Valuation

PHIO has a market cap or net worth of $1.86 million. The enterprise value is -$3.53 million.

Market Cap	1.86M
Enterprise Value	-3.53M

Important Dates

The last earnings date was Thursday, November 14, 2024, after market close.

Earnings Date	Nov 14, 2024
Ex-Dividend Date	n/a

Share Statistics

PHIO has 1.06 million shares outstanding. The number of shares has increased by 226.77% in one year.

Current Share Class	1.06M
Shares Outstanding	1.06M
Shares Change (YoY)	+226.77%
Shares Change (QoQ)	+94.05%
Owned by Insiders (%)	0.37%
Owned by Institutions (%)	2.96%
Float	1.05M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.34
P/TBV Ratio	0.38
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 6.38

Current Ratio	6.38
Quick Ratio	5.87
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -122.03% and return on invested capital (ROIC) is -75.72%.

Return on Equity (ROE)	-122.03%
Return on Assets (ROA)	-60.11%
Return on Capital (ROIC)	-75.72%
Revenue Per Employee	n/a
Profits Per Employee	-$824,333
Employee Count	9
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -74.27% in the last 52 weeks. The beta is 1.46, so PHIO's price volatility has been higher than the market average.

Beta (5Y)	1.46
52-Week Price Change	-74.27%
50-Day Moving Average	2.76
200-Day Moving Average	4.62
Relative Strength Index (RSI)	29.63
Average Volume (20 Days)	345,562

Short Selling Information

The latest short interest is 48,124, so 4.56% of the outstanding shares have been sold short.

Short Interest	48,124
Short Previous Month	47,983
Short % of Shares Out	4.56%
Short % of Float	4.58%
Short Ratio (days to cover)	0.50

Income Statement

Revenue	n/a
Gross Profit	-3.67M
Operating Income	-7.41M
Pretax Income	-9.38M
Net Income	-7.42M
EBITDA	-7.40M
EBIT	-7.41M
Earnings Per Share (EPS)	-$12.64

Balance Sheet

Cash & Cash Equivalents	5.39M
Total Debt	n/a
Net Cash	5.39M
Net Cash Per Share	$5.11
Equity (Book Value)	4.95M
Book Value Per Share	5.16
Working Capital	4.95M

Cash Flow

Operating Cash Flow	-8.11M
Capital Expenditures	n/a
Free Cash Flow	-8.11M
FCF Per Share	-$7.69

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

PHIO does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-226.77%
Shareholder Yield	-226.77%
Earnings Yield	-399.48%
FCF Yield	-436.74%

Analyst Forecast

The average price target for PHIO is $36.00, which is 1,945.46% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$36.00
Price Target Difference	1,945.46%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Splits

The last stock split was on July 5, 2024. It was a reverse split with a ratio of 0.1111111:1.

Last Split Date	Jul 5, 2024
Split Type	Reverse
Split Ratio	0.1111111:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	1